Cart 0

1st of 3 parts examining the treatment of Atrial Fibrillation (AF)

Posted by Eamonn Brady on

Atrial fibrillation Treatment Part 1


I discussed causes and symptoms of Atrial Fibrillation (AF) in previous weeks in this column.


Aims of AF management are to:

  • Relieve symptoms, such as palpitations, tiredness, dizziness, and breathlessness
  • Prevent serious complications, such as stroke and CHF
  • Regulate heart rate
  • Treat the cause of AF where identifiable




Medication used to slow the heart rate include:

  • Beta-blockers (atenolol, metoprolol)
  • Digoxin
  • Dihydropyridine calcium channel blockers (CCBs) (e.g.) verapamil, diltiazem
  • Amiodarone (less often used due to risk of side effects)


Beta blockers such as atenolol and metoprolol are used to control ventricular rate in AF.

Dihydropyridine calcium channel blockers (CCBs) such as diltiazem or verapamil as monotherapy are an option for ventricular rate control in AF. Dihydropyridine CCBs have the effect relaxing and widening blood vessels as well as the additional effects of being rate limiting meaning they decrease myocardial contractility and heart rate.

The choice of use of beta blockers versus dihydropyridine CCBs is based on type of symptoms, heart rate and the presence of other conditions. 

Studies indicate digoxin is less effective than CCBs and amiodarone at controlling heart rate acutely (i.e.) need for fast rate control. Digoxin is more effective at controlling ventricular rate when the patients are at rest so is reserved as monotherapy for AF patients with a sedentary lifestyle and for non-paroxysmal AF, especially those with left ventricular systolic dysfunction. Digoxin is used when beta-blockers do not give sufficient rate control and where beta blockers are poorly tolerated and/or contraindicated.


A single drug may not be sufficient to control ventricular rate so a combination of two drugs such as a beta-blocker, digoxin, or diltiazem is the next option. When ventricular function is reduced, the combination of a beta-blocker and digoxin is preferred option.

BPro Cardio Screen Service

Measures artery stiffness to identify risk of blockages and cardiovascular and circulatory disease. BPRo is placed like a watch on your wrist and is pain free. A pulse wave reads and calculates a wave signal that indicates the elasticity of large, small, and peripheral artery walls as well as tests for stress, central blood pressure, heart rate, and more. It is now €35 (was €50); it only takes about 15 minutes. The next clinic is Saturday September 24th (from 9am to 5pm) at Whelehans Pearse St. Book online on the Whelehans Website or by calling Whelehans at 04493 34591.

To be continued…next week


Disclaimer: BPro Cardio is not an alternative to medical assessment; it can indicate risk of cardiovascular events but is not a diagnosis

For comprehensive and free health advice and information call in to Whelehans, log on to or dial 04493 34591 (Pearse St) or 04493 10266 (Clonmore) or

Share this post

← Older Post Newer Post →